« Return to News | CROs/Service Providers

Unimed CRO Retools Name, Management

Friday, January 22, 2010 12:25 PM

Unimed, a contract research organization (CRO) in Prague, announced a name change and new management, following the final integration of its operations throughout Central and Eastern Europe.  The newly branded CRO—EastHORN—will continue to offer phase I to phase IV clinical trial services throughout the CEE region but plans to expand its reach to other countries within the region and perhaps as far as China and Africa in the future. The company has offices in Prague and Warsaw, as well as newly established offices in Bulgaria and Romania.

Founded as Unimed in 2004 by Ales Horacek, M.D., EastHORN is now managed by former AbCRO president Malgorzata Szerszeniewska, M.D.  AbCRO was acquired by PPD last year. Szerszeniewska also spent 11 years at Covance where she held various positions. Both Covance and AbCRO were partners of Unimed. Alan Wood, Ph.D., also a former Covance executive, will serve as chairman of the board of directors for EastHORN. Horacek remains with the company as chief operative officer.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.